Improving Post-Prandial Blood Glucose Control With Afrezza During Closed-Loop Therapy

What is the purpose of this trial?

The study will be conducted in two phases; an in-patient meal study phase (Phase I) and an outpatient home study (Phase II). The two phase study design is chosen to enhance safety by testing the Afrezza Closed-Loop (CL) system in controlled in-clinic setting under study staff supervision before it could be investigated at the outpatient home setting. Phase II will not begin without the establishment of safety in Phase I.

The age inclusion criterion is 18-29 years for phase I and 18-50y for phase II. Only recruiting for phase I (18-29) currently.


Participation Guidelines

Ages: 18 - 50 years

Gender: Both


Juvenile Diabetes Research Foundation International

Start Date: 10/01/2017

End Date: 02/28/2021

Last Updated: 06/22/2018

Study HIC#: 2000020715

Get Involved

For more information about this study, contact:
Kristen Kraemer
+1 631-275-8634
kristen.kraemer@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Eda Cengiz

Principal Investigator

Sub-Investigators